ASXL1 as a critical regulator of epigenetic marks and therapeutic potential of mutated cells

Detalles Bibliográficos
Autores principales: Inoue, Daichi, Fujino, Takeshi, Kitamura, Toshio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6219660/
https://www.ncbi.nlm.nih.gov/pubmed/30443287
http://dx.doi.org/10.18632/oncotarget.26230

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6219660/
https://www.ncbi.nlm.nih.gov/pubmed/30443287
http://dx.doi.org/10.18632/oncotarget.26230

Ejemplares similares